Results 151 to 160 of about 112,281 (276)

Prognostic factors and treatment outcomes in female genital tract melanoma: a 10-year retrospective cohort study. [PDF]

World J Surg Oncol
Mao M, Wang C, Yang W, Zuo Z, Liu B.
europepmc   +1 more source

Survival outcomes and prognostic factors of gastric carcinoma with neuroendocrine differentiation

International Journal of Cancer, Volume 158, Issue 9, Page 2209-2218, 1 May 2026.
What's new? Although gastric carcinoma with neuroendocrine differentiation (GCNED) is associated with more aggressive features than conventional GC, its prognosis and survival remain poorly defined. To better understand survival patterns, the authors of the present study examined clinicopathological and prognostic features of GCNED patients following ...
Jinjin Li, Chenglong Wang, Yifan Shen, Zhen Huang, Jun Zhang, Siqi Rao, Youde Cao, Jiang Min   +7 more
wiley   +1 more source

Inflammatory myofibroblastic tumor of female genital tract with unusual features and potential diagnostic pitfalls. [PDF]

Front Oncol
Zhang H, Chen L, Lin Y, Lu T, Gao Y, Luo D, Xu S.   +6 more
europepmc   +1 more source

Observational study of metastatic vulvar Crohn's disease in the pediatric population

JPGN Reports, Volume 7, Issue 2, Page 207-212, May 2026.
Abstract Objective Metastatic vulvar Crohn's disease (MVCD) is a rare cutaneous manifestation of Crohn's disease (CD), especially in pediatric patients. The objective of this study is to assess presentation, diagnosis, and treatment for pediatric MVCD in the largest cohort reported. Methods This is a retrospective review of pediatric patients with MVCD
Deborah Winograd, Afua Addo, Taryn Wassmer, Jennifer Hellmann, Daniel Mallon, Kalyani Marathe, Christine Pennesi   +6 more
wiley   +1 more source

The Impact of Endocrine Disruptors on the Female Genital Tract Microbiome: A Narrative Review. [PDF]

Life (Basel)
Moustakli E, Grigoriadis T, Potiris A, Drakaki E, Zikopoulos A, Anagnostaki I, Zachariou A, Domali E, Drakakis P, Stavros S.   +9 more
europepmc   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld, Nicole Kasatkin, Bi Liu Yu, Milen Velinov, Justin S. Brandt, Elena Ashkinadze   +5 more
wiley   +1 more source

Methods of Suicide Used by People With Cancer: A Scoping Review

Psycho-Oncology, Volume 35, Issue 5, May 2026.
ABSTRACT Background Individuals diagnosed with cancer are at increased risk of suicide compared to the general population. Access to means is a key volitional risk factor for suicide and represents a modifiable target for prevention at a population level.
Doireann Ni Dhalaigh, Zubair Kabir, Fahmi Ismail, Paul Corcoran, Daisy Wiggin, Eugene Cassidy   +5 more
wiley   +1 more source

NTRK-rearranged spindle cell neoplasm of the female genital tract: case report and literature review. [PDF]

Front Oncol
Feng L, Li L, He Y, Jiang W.
europepmc   +1 more source

Proteomic Analysis of Cervicovaginal Fluid for Diagnostic Endometriosis Biomarker Discovery

PROTEOMICS – Clinical Applications, Volume 20, Issue 3, May 2026.
ABSTRACT Purpose Endometriosis is a prevalent inflammatory condition characterised by the presence of endometrial‐like tissue outside the uterus and is associated with significant challenges, including diagnostic delays and continued reliance on laparoscopy.
Emily S. J. Paterson, Simon Scheck, Torsten Kleffmann, Roopi Gill, Nicholas Bedford, Simon McDowell, Jane E. Girling, Claire E. Henry   +7 more
wiley   +1 more source

Tumor-Infiltrating Lymphocytes in Breast and Female Genital Tract Cancers: Overlooked Potential and Unexplored Frontiers. [PDF]

Cancer Med
Skok K, Maccio U, Martin SD, Bräutigam K.   +3 more
europepmc   +1 more source